(WAFB) - Another manufacturer of medications that include Ranitidine as an ingredient is pulling its products from shelves because of the potential presence of the same probable cancer-causing impurity that prompted earlier recalls of several blood pressure medications.
The U.S. Food and Drug Administration (FDA) had published Amneal Pharmaceuticals’ voluntary recall on Friday, Nov. 22 of 150 mg and 300 mg tablets and 15 mg/mL syrup.
The pharmaceutical company said it has not received any reports of adverse events that have been confirmed to be directly related to this recall.
The FDA first learned on Friday, Sept. 13 that similar medicines containing Ranitidine were possibly contaminated with small amounts of a substance called N-nitrosodimethylamine (NDMA). NDMA is classified as a probable human carcinogen.
Consumers who use the recalled Ranitidine tablets and Ranitidine syrup are urged to immediately stop using the product and can call Stericycle at 866-918-8768, Monday through Friday between 8 a.m. to 5 p.m. for more information.
The full list of recalled products and be viewed by clicking the link here.
Consumers can find previously recalled products that include Ranitidine by clicking the link here.
Join the 9News Alert Team Facebook Group for more consumer and safety alerts.